Phospho-DLP1 (Ser616)抗体特异性结合抗原：抗体本身不能直接溶解或杀伤带有特异抗原的靶细胞，通常需要补体或吞噬细胞等共同发挥效应以**病原微生物或导致病理损伤。然而，抗体可通过与病毒或**的特异性结合，直接发挥中和病毒的作用。
产物编号xy- 11249R
英文名称Phospho-DLP1 (Ser616)
中文名称磷酸化动力相关蛋白1抗体
别 名p-DLP1 (Ser616); DLP1 (phospho S616); DLP1 (phospho Ser616); p-DLP1 (S616); DLP1; dnm1l; DNM1L_HUMAN; Dnm1p/Vps1p-like protein; DRP 1; DRP-1; DVLP; Dymple; Dynamin 1 like; Dynamin family member proline-rich carboxyl-terminal domain less; Dynamin like protein; Dynamin related protein 1; Dynamin-1-like protein; Dynamin-like protein 4; Dynamin-like protein; Dynamin-like protein IV; Dynamin-related protein 1; DYNIV 11; FLJ41912; HdynIV; VPS1.
说 明 书100ul
产物类型磷酸化抗体
研究领域肿瘤 **学 神经生物学 信号转导 细胞凋亡 转运蛋白 线粒体
抗体来源搁补产产颈迟
克隆类型笔辞濒测肠濒辞苍补濒
Phospho-DLP1 (Ser616)抗体交叉反应 Human, Mouse, Rat, Chicken, Dog, Cow, Rabbit, Sheep,
产物应用WB=1:500-2000 ELISA=1:500-1000 IHC-P=1:400-800 IHC-F=1:400-800 ICC=1:100-500 IF=1:100-500 （石蜡切片需做抗原修复）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量82kDa
细胞定位细胞浆 细胞膜 线粒体
性 状Lyophilized or Liquid
浓 度1mg/1ml
免 疫 原KLH conjugated synthesised phosphopeptide derived from human DLP1 around the phosphorylation site of Ser616:PA(p-S)PQ
亚 型IgG
纯化方法affinity purified by Protein A
储 存 液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Phospho-DLP1 (Ser616)抗体保存条件Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
PubMedPubMed
产物介绍产补肠办驳谤辞耻苍诲:
The protein encoded by this gene is a member of the dynamin superfamily of GTPases. Members of the dynamin-related subfamily, including the S. cerevisiae proteins Dnm1 and Vps1, contain the N-terminal tripartite GTPase domain but do not have the pleckstrin homology or proline-rich domains. This protein establishes mitochondrial morphology through a role in distributing mitochondrial tubules throughout the cytoplasm. The gene has 3 alternatively spliced transcripts encoding different isoforms. These transcripts are alternatively polyadenylated. [provided by RefSeq, Jul 2008].
Function:
Functions in mitochondrial and peroxisomal division. Mediates membrane fission through oligomerization into ring-like structures which wrap around the scission site to constict and sever the mitochondrial membrane through a GTP hydrolysis-dependent mechanism. Required for normal brain development. Facilitates developmentally-regulated apoptosis during neural tube development. Required for a normal rate of cytochrome c release and caspase activation during apoptosis. Also required for mitochondrial fission during mitosis. Required for programmed necrosis execution. May be involved in vesicle transport.
Isoform 1 and isoform 4 inhibit peroxisomal division when overexpressed.
Subunit:
Homotetramer; dimerizes through the N-terminal GTP-middle region of one molecule binding to the GED domain of another DNM1L molecule. Can self-assemble in multimeric ring-like structures. Interacts with BCL2L1; the interaction stimulates the GTPase activity of DMN1L in synapses and increases the number of axonal mitochondria and the size and number of synaptic vesicle clusters. Interacts with FIS1 (By similarity). Interacts with GSK3B and MARCH5. Interacts (via the GTPase and B domains) with UBE2I; the interaction promotes sumoylation of DNM1L, mainly in ite B domain. Interacts with PPP3CA; the interaction dephosphorylates DNM1L and regulates its transition to mitochondria. Interacts witn MID49 and MID51. Interacts with PGAM5; this interaction leads to dephosphorylation at Ser-637 and activation of GTPase activity and eventually to mitochondria fragmentation.
Subcellular Location:
Cytoplasm, cytosol. Golgi apparatus. Endomembrane system; Peripheral membrane protein. Mitochondrion outer membrane; Peripheral membrane protein. Note=Mainly cytosolic. Translocated to the mitochondrial membrane through O-GlcNAcylation and interaction with FIS1. Colocalized with MARCH5 at mitochondrial membrane. Localizes to mitochondria at sites of division. Localizes to mitochondria following necrosis induction. Associated with peroxisomal membranes, partly recruited there by PEX11B. May also be associated with endoplasmic reticulum tubules and cytoplasmic vesicles and found to be perinuclear. In some cell types, localizes to the Golgi complex.
Tissue Specificity:
Ubiquitously expressed with highest levels found in skeletal muscles, heart, kidney and brain. Isoform 1 is brain-specific. Isoform 2 and isoform 3 are predominantly expressed in testis and skeletal muscles respectively. Isoform 4 is weakly expressed in brain, heart and kidney. Isoform 5 is dominantly expressed in liver, heart and kidney. Isoform 6 is expressed in neurons.
Post-translational modifications:
Phosphorylation/dephosphorylation events on two sites near the GED domain regulate mitochondrial fission. Phosphorylation on Ser-637 inhibits mitochondrial fission probably through preventing intramolecular interaction. Dephosphorylated on this site by PPP3CA which promotes mitochondrial fission. Phosphorylation on Ser-616 also promotes mitochondrial fission.
Sumoylated on various lysine residues within the B domain, probably by MUL1. Sumoylation positively regulates mitochondrial fission. Desumoylated by SENP5 during G2/M transition of mitosis. Appears to be linked to its catalytic activity.
S-nitrosylation increases DNM1L dimerization, mitochondrial fission and causes neuronal damage.
Ubiquitination by MARCH5 affects mitochondrial morphology.
O-GlcNAcylation augments the level of the GTP-bound active form of DRP1 and induces translocation from the cytoplasm to mitochondria in cardiomyocytes. It also decreases phosphorylation at Ser-637.
DISEASE:
Note=May be associated with Alzheimer disease through beta-amyloid-induced increased S-nitrosylation of DNM1L, which triggers, directly or indirectly, excessive mitochondrial fission, synaptic loss and neuronal damage.
Defects in DNM1L are the cause of encephalopathy, lethal, due to defective mitochondrial and peroxisomal fission (EMPF) [MIM:614388]. EMPF is a rare autosomal dominant systemic disorder resulting in lack of neurologic development and death in infancy. After birth, infants present in the first week of life with poor feeding and neurologic impairment, including hypotonia, little spontaneous movement, no tendon reflexes, no response to light stimulation, and poor visual fixation. Other features include mildly elevated plasma concentration of very-long-chain fatty acids, lactic acidosis, microcephaly, deep-set eyes, optic atrophy and hypoplasia, and an abnormal gyral pattern in both frontal lobes associated with dysmyelination.
Similarity:
Belongs to the dynamin family.
SWISS:
O00429
Gene ID:
10059
Phospho-DLP1 (Ser616)抗体（antibody,
Ab）是由效应B细胞（效应**B细胞）分泌，机体用于抵御外来物质，如病毒，**等抗原，结构呈“驰”字型的球状蛋白质，仅仅存在于脊椎动物的血液和B**细胞膜表面。凡是能够跟抗体结合的物质，均被称作抗原，因此对于抗抗体（能够结合抗体的抗体）来说，抗体本身也是一种抗原物质。
Phospho-DLP1 (Ser616)抗体普通抗体重链和轻链的结构
重链结构：普通的**球蛋白具有2条重链（H链），分子量约为50kD,有μ、δ、γ、ε和α五种重链亚型，对应的**球蛋白名称分别为IgM、IgG、IgA、IgD和IgE。
轻链结构： 普通**球蛋白具有2条轻链（L链），分子质量约25kDa，有κ链和λ链两种亚型，这两种轻链决定了Ig的亚型类别（IgG1，IgG2，IgG3，IgG4）。一个天然的Ig分子两条轻链总是相同的，但在同一个体内可存在分别带有κ或λ链的抗体分子。不同种属生物体内两型轻链的比例不同，正常人血清**球蛋白κ链：λ链约为2：1，而在小鼠的比例为20：1。
2.2抗体Fab段和Fc段
滨驳骋经木瓜蛋白酶酶切后裂解为2个完全相同的Fab段和1个Fc段,每个Fab段都为单价,可与抗原结合但不会再发生凝集反应；经胃蛋白酶酶切后裂解为1个完整F(ab)2片段和碎片化的Fc片段,F(ab’)2片段为双价,可同时结合两个抗原表位。Fab段为抗原结合片段（fragment of antigen binding，Fab），相当于抗体分子的两个臂，由一个完整的轻链和重链的VH和CH1结构域组成。Fc段为可结晶段（fragment crystallizable，Fc）相当于Ig的CH2和CH3结构域，是Ig与效应分子或者细胞相互作用的部位。Fab段包含完整的可变区，以及恒定区的CH1区域。Fc段仅指Ig恒定区CH2和CH3的区域，相当于Y字结构下面那一部分。
合格 NCR1 细胞毒性受体NK-p46抗体
合格 Nectin 4 脊髓灰质炎病毒受体相关蛋白4抗体
合格 Newcastle disease virus 鸡新城疫病毒抗体
合格 ACE2 血管紧张素转换酶2抗体
合格 合格 DC-SIGN 细胞间粘附分子非整合素蛋白3抗体
合格 GPR48 G蛋白偶联受体48抗体
合格 RIP1 受体相互作用蛋白1抗体
合格 MMP19 基质金属蛋白酶18/19抗体
合格 合格 HGFA Inhibitor 2 肝细胞生长因子激活抑制蛋白2抗体
合格 Lymphotoxin Beta 肿瘤坏死因子C/****β抗体
合格 SP-C 肺表面活性蛋白C抗体
合格 合格 Cytokeratin 4 细胞角蛋白4抗体
合格 VEGFB 血管内皮生长因子B
合格 合格 PDGF-A 血小板源性生长因子A抗体
合格 MUC13 粘蛋白13抗体
合格 Brain2 大脑蛋白2抗体
合格 GPR109A G蛋白偶联受体109A抗体
合格 Dopamine Receptor D1 多巴胺受体D1抗体
合格 Fibrinopeptide A 纤维蛋白肽A抗体
合格 Dopamine D2 Receptor 多巴胺受体D2抗体
合格 BMP6 骨形态发生蛋白6抗体
合格 PLAG1 多型性腺瘤基因1蛋白抗体
合格 合格 CYP11A1 细胞色素P450 11A1抗体
合格 合格 phospho-Tau (Ser579) 磷酸化微管相关蛋白抗体
合格 phospho-Ron (Tyr1238+Tyr1239) 磷酸化原癌基因c-Met相关酪氨酸激酶抗体
合格 CXCR4 细胞表面趋化因子受体4抗体
合格 phospho-CD130/gp130 (Ser782) 磷酸化gp130抗体
合格 合格 CDKN1A/P21 p21蛋白抗体
合格 phospho-AKT1 (Tyr474) 磷酸化蛋白激酶AKT1抗体
合格 phospho-Eph receptor B1 (Tyr928) 磷酸化酪氨酸蛋白激酶受体B1抗体
合格 phospho-Eph receptor B1 (Tyr968) 磷酸化酪氨酸蛋白激酶受体B1抗体
合格 CD35 Ⅰ型补体受体抗体（C3b/C4b受体抗体）
合格 hnRNP M 异质性核糖核蛋白M抗体
合格 合格 CD11b 整合素αM/巨噬细胞表面分子抗体
合格 Exportin 1 染色体区域稳定蛋白/核输出蛋白1抗体
合格 PD-L1 程序性死亡配体1抗体
合格 ALDH1 乙醛脱氢酶1型抗体